Europe Communications Director — Oncology Impact

BeOne Medicines; Basel; On-site; CHF 120,000 - 180,000; Full time

Benefits offered by this job

Professional development

Global collaboration

Competitive benefits

International team

Impact on patients

Job summary

BeOne Medicines is a global oncology company seeking a communications professional to lead European market strategies and public relations efforts. You will manage media outreach, content creation, and stakeholder relationships to ensure consistent brand messaging across channels.

Experience in the European pharmaceutical landscape and oncology communications is preferred. The role offers a dynamic, global environment and opportunities to contribute to advancing cancer treatments.

Qualifications

• Proven experience in communications and public relations.
• Strong understanding of the European pharmaceutical landscape.
• Excellent written and verbal communication skills.
• Ability to manage multiple projects simultaneously.
• Experience in the oncology field preferred.
• Experience with reporting adverse events.

Responsibilities

• Develop and implement communication strategies for the European market.
• Manage public relations and media outreach efforts.
• Oversee the creation of content for various channels.
• Build and maintain relationships with key stakeholders.
• Ensure brand consistency across all communications.
• Report adverse events related to products.

Skills

Public relations

Communications

Stakeholder management

Adverse event reporting

Job description

BeOne Medicines is a global oncology company seeking a communications professional to lead European market strategies and public relations efforts. You will manage media outreach, content creation, and stakeholder relationships to ensure consistent brand messaging across channels.

Experience in the European pharmaceutical landscape and oncology communications is preferred. The role offers a dynamic, global environment and opportunities to contribute to advancing cancer treatments.